MARK1 and neoplasm: Further, it has been reported that LKB1 loss-mediated epithelial-to-mesenchymal transition (EMT) occurs through the downstream kinases MARK1 and 4 [32], not AMPK, suggesting an AMPK-independent signaling pathway that is essential for LKB1-dependent control of tumor aggressiveness.